Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies

Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies

Pediatric-onset multiple sclerosis (POMS) refers to multiple sclerosis occurring in individuals under 18 years of age. It is characterized by poor cognitive outcomes and a more inflammatory course, more frequent clinical relapses, and a greater number of MRI lesions compared to adult-onset MS (AOMS)...

Full description

Saved in:
Bibliographic Details
Main Authors: Lama Saleh Aljomah, E. Ann Yeh
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Neurotherapeutics
Subjects:
Pediatric-onset multiple sclerosis
Demyelinating disease
Disease-modifying therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1878747925001096
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items